El Hospital Universitario De Gran Canaria Dr. Negrin — Clinical Trial Site

164 Registered trials

69 Currently recruiting

Organisation

El Hospital Universitario De Gran Canaria Dr. Negrin

Location

Las Palmas De Gran Canaria, Spain

Identifier

ORG-100043578

Address

Barranco De La Ballena Sn, 35010, Spain

Departments

-
#2311:servicio de neurología
#2353: Servicio de dermatología
#3404: Cardiología
#40294: Dermatología
#7003: Hematologia y Transfusión
#7013:Dermatología
#7503: Servicio Dermatología
#9004:Dermatología
172418: Hematología
2604: Cardiology
2750; Dermatología
2806:Dermatología
2808: Cardiologia
2902: Hematology
3120: Cardiología
3503: Cardiologia
6507: Dermatología
7209: Neurology
9009: Neurology
9256: Servicio Dermatología
9755; Dermatología
Alergología
Alergology
Allergology
Allergy
Analisis Clínicos
Cardiología
Cardiology
Cirugía
Clinical Haematology
Departamento de Neurología
Dermatología
Dermatology
Digestive
Digestive Department
Digestive Service
Digestive system
Digestivo
ES050A: Hematología
ES30002: Hematologia y Transfusión
Gastroenterología
Gastroenterology
Haematology
Haematology and Haemotherapy
Hematología
Hematology
Hematology Department
Hematology Service
Hosp. Gran Canaria Dr. Negrín_Cardiology service
Hosp. U Gran Canaria Dr. Negrín_Cardiologia
Hospital Universitario de Gran Canaria Doctor Negrín
Internal medicine- Infectious Disease Department
N/A
Neumología
Neurología
Neurology
Neurology department
Oncología Radioterápica
Oncology
Otorrinolaringología
Pneumology Service
Radiation Oncology
Radiotherapy oncology service
Research Unit, Chronic Pain Unit, Radiation Oncology Department
Respiratory medicine
Respiratoy Medicine
Restiratoy Medicine
Reumatología
Servicio de digestivo
Servicio de Aparato Digestivo
Servicio de Dermatología
Servicio de Digestivo
Servicio de Hematología
Servicio de Medicina Interna
Servicio de Neurologia
Surgery
Thoracic Oncology

Clinical trials at this site (164)

Search interface

A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting

2025-522860-34-00 Chronic lymphocytic leukemia (CLL) 5 2025-12-16
A Study to Assess Bioequivalence of Two Subcutaneous Formulations of Ocrelizumab in Participants with Multiple Sclerosis Recruiting

2024-517980-22-00 Multiple Sclerosis (MS) 4 2025-12-10
Platform study to evaluate the efficacy and safety of investigational compound(s) in patients with moderate to severe atopic dermatitis Recruiting

2024-519081-49-00 Moderate to severe atopic dermatitis 4 2025-10-28
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Study of Ruxolitinib Cream in Participants with Hidradenitis Suppurativa (TRuE-HS2) Recruiting

2024-517633-40-00 Hidradenitis Suppurativa 5 2025-09-18
A study to investigate the efficacy and safety of brivekimig in adult participants with ulcerative colitis. Recruiting

2024-515241-41-00 Ulcerative Colitis 4 2025-09-10
A phase III placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing… Recruiting

2024-512752-38-00 Adjunctive and maintenance treatment to HCT 5 2025-09-09
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme… Recruiting

2023-508875-35-00 Heart condition 5 2025-09-01
Study of the treatment of patients with non-small cell lung cancer with metastasis with Cemiplimab and subsequent treatment with Cemiplimab … Recruiting

2024-518812-38-00 Non-small cell lung cancer (NSCLC) 4 2025-07-02
"A research study comparing different doses of CDR132L with placebo on the structure and function of the heart in people with heart failure … Recruiting

2024-515796-35-00 Heart Failure with Preserved Ejection Fraction and Left 4 2025-06-26
A research study comparing CDR132L with placebo on the structure and function of the heart in people with heart failure with reduced/mildly … Recruiting

2024-515797-27-00 Heart Failure with Reduced/Mildly Reducede Ejection Fra 4 2025-06-25
Study to treat adult patients with BCR-ABL1+ Chronic Myeloid Leukemia with Asciminib as single agent or in combination with nilotinib:a GIME… Recruiting

2024-512696-12-00 BCR-ABL1+ Chronic Myeloid Leukemia 4 2025-06-24
A phase 3 multicenter, randomised, prospective, open-label trial of fixed-duration (12 cycles) venetoclax/ obinutuzumab vs. fixed-duration (… Recruiting

2023-510294-34-00 small lymphocytic lymphoma (SLL) 5 2025-06-12
Phase II clinical trial of chemotherapy + atezolizumab for stage IIIa and IIIb non-small cell lung cancer followed by atezolizumab as adjuva… Recruiting

2024-515984-68-00 Non-small cell lung cancer (NSCLC) 4 2025-05-20
A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-t… Recruiting

2024-512496-12-00 Moderate to Severe Plaque Psoriasis 5 2025-04-01
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chroni… Recruiting

2023-510292-65-00 chronic graft-versus-host disease 5 2025-02-25
Ozone treatment in patients with numbness and/or tingling secondary to chemotherapy. Randomized clinical trial. Recruiting

2024-517196-20-00 Paresthesia (numbness, tingling) secondary to chemother 10 2025-02-07
Study of treatment with sacituzumab and zimkberelimab for patients with lung cancer confined to the chest and previously operated on who wer… Recruiting

2024-512960-75-00 Resectable Non-small cell lung cancer 5 2025-02-04
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease ( ENHANCE-CD ) Recruiting

2023-508234-34-00 Crohn's disease 4 2025-01-27
Treatment with a single drug that prevents blood clot formation followed by an anticoagulant drug in patients with irregular heartbeat who h… Recruiting

2023-509717-36-00 AF patients who have undergone successful PCI 5 2024-12-16
LATE-R trial. A Phase II, Single-Arm, Open-Label, Multicenter Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients with Lat… Recruiting

2024-512835-53-00 Diffuse Large B-Cell Lymphoma 4 2024-11-20
Letermovir (LMV) prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients with CMV seropositive donors Recruiting

2024-516011-24-01 Cytomegalovirus infection in allogeneic stem cell trans 4 2024-11-13
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis Recruiting

2023-504724-25-00 Primary Myelofibrosis 5 2024-10-16
202301CPC Redefine-HF Recruiting

2023-508581-15-00 Heart condition 5 2024-10-08